Variants in FTO , GLP1R , and MC4R shape appetite, receptor signaling, and energy balance
They nudge similar pathways, but the effects are usually modest
This includes eligibility screening, dose titration, a critical phase in tirzepatide therapy where doses advance from the 2.5 mg starting dose through escalating levels (5 mg, 7.5 mg, 10 mg, and 12.5 mg or 15 mg), and ongoing monitoring of metabolic and clinical outcomes
Storer, Thomas W et al
*Correspondence: Bin Ding, [email protected] These authors have contributted equally to this work This article was submitted to Ethnopharmacology, a section of the journal Frontiers in Pharmacology Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
Modulation of Renal Apical Organic Anion Transporter 4 Function by Two PDZ Domain-Containing Proteins